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Hybrid Nonribosomal Peptide-Polyketide Interfaces
in Epothilone Biosynthesis: Minimal Requirements
at N and C Termini of EpoB for Elongation
pertain to biosynthetic engineering efforts [15]. While both
rely on thio-templated mechanism for monomer activation
and acyl chain growth, these two types of pathways use
different classes of building blocks, proteinogenic or mod-
ified amino acids for NRPS, and acyl-CoAs for PKS.
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Boston, Massachusetts 02115 The chemistry that drives iterative elongation is thus
fundamentally different in these two systems. In an
NRPS pathway, the elongation involves carbon-nitrogen
bond formation between the carbonyl group of the up-Summary
stream acyl donor and the amino group of the down-
stream amino-acyl acceptor, both attached to peptideEpothilone (Epo) D, an antitumor agent currently in
carrier protein (PCP) domains. In a PKS pathway, theclinical trials, is a hybrid natural product produced by
upstream and downstream acyl groups, attached to acylthe combined action of nonribosomal peptide synthe-
carrier protein (ACP) domains, couple through Claisen-tases (NRPS) and polyketide synthases (PKS). In the
type carbon-carbon bond formation. In addition, theseepothilone biosynthetic pathway, EpoB, a 165 kDa
two systems have shown variant protein-protein inter-NRPS is inserted into an otherwise entirely PKS as-
face characteristics. PKS proteins are dimeric [16, 17],sembly line, forming two hybrid NRPS-PKS interfaces.
in contrast to S proteins predominantly found as mono-In light of the terminal linker effect previously identified
mers [18–22].in PKS, the N- and C-terminal sequences of EpoB were
Currently unknown are the details of molecular recogni-examined for their roles in propagating the incipient
tion events that allow hybrid NRP-PK pathways to func-natural product. Eight amino acid residues at EpoB C
tionally accommodate different assembly-line chemicalterminus, in which six are positively charged, were
logics with divergence in quaternary organization. Elucida-found to be a key component of the C-terminal linker
tion of molecular interactions that govern recognition ateffect. A minimal sequence of 56 residues at EpoB N
these interfaces therefore will be a prerequisite to sus-terminus was required for elongating the acetyl group
tainable pathway engineering strategies. Informationfrom the acyl carrier protein (ACP) of EpoA to form
gathered on NRP and PK systems so far provides invalu-methylthiazolyl-S-EpoB.
able leads in studying hybrid NRP-PK systems. One of
the most significant discoveries is the shuffling of PKS
Introduction subunits facilitated by N- and C-terminal linkers [23–27].
A similar linker hypothesis has been proposed for the
Nonribosomal peptide synthethases (NRPS) and polyke- hybrid NRP-PK systems based on primary sequence
tide synthases (PKS) are multimodular enzymes that analysis [28]. The concept of portable docking units for
synthesize secondary metabolites from small mono- proteins otherwise unrecognizable to each other is very
meric building blocks in assembly-line format [1–4]. In attractive to engineering pathway reconstruction in hy-
both cases, each module, equipped with multiple cata- brid -PK biosynthetic machineries as an approach par-
lytic domains, is responsible for incorporating one build- ticularly relevant to drug discovery [29–32].
ing block, receiving the growing acyl chain from an up- The epothilone biosynthetic pathway, whose PKS/
stream module and elongating the incipient natural NRPS/PKS hybrid interfaces (EpoA/B/C subunits) have
product for transfer to the next module down the assem- recently been reconstituted [33, 34], emerges as a good
bly line. The fully elongated natural product after release system for investigating the linker hypothesis (Figure 1).
from assembly lines can be further modified, decorated, The two hybrid interfaces are formed by the initial three
or conformationally constrained by a variety of tailoring protein subunits of the pathway, EpoA, EpoB, and EpoC.
enzymes acting either in trans or in cis. The modular EpoB, inserted between two PKS subunits, is the only
nature of these pathways has inspired the concept of NRPS protein in the otherwise entirely PKS pathway.
combinatorial biosynthesis for generating “unnatural” EpoB is responsible for accepting the upstream acetyl
natural products for therapeutic applications [5, 6]. Hy- group presented by EpoA-ACP and, as cysteinyl-S-
brid NRP/PK natural products, produced by pathways EpoB, elongating it to the methylthiazolyl intermediate.
containing both types of enzymes, further expand the This transformation involves multiple chemical steps
perspective of combinatorial biosynthesis. Representa- controlled by the cyclization (Cy), adenylation (A), and
tive examples of hybrid NRP-PK natural products with oxidation (Ox) domains of EpoB. The A domain is responsi-
medicinal importance include rapamycin (immunosup- ble for activating L-cysteine (L-Cys) as an aminoacyl-AMP.
pressant), bleomycin (anticancer), epothilone (microtu- The thiol group of the phosphopantetheinyl prosthetic
bule binder), yersiniabactin (siderophore), and leina- arm of holo-PCP domain of EpoB reacts with Cys-AMP
mycin (antibiotic) [7–14]. to form Cys-S-EpoB-PCP as the competent downstream
Questions concerning the biosynthesis of hybrid NRP- amino-acyl group to couple with the incoming acetyl
PK natural products are of current interest as their answers group. The resulting N-acetyl-Cys intermediate is cy-
clized and dehydrated to form the methylthiazolinyl ring
by the action of the Cy domain before being oxidized*Correspondence: christopher_walsh@hms.harvard.edu
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Figure 1. The Epothilone Biosynthesis
(A) Structure of epothilone D, a representative
member of the epothilone family.
(B) Gene cluster of epothilone biosynthesis.
(C) The initial three enzyme subunits that form
the PKS/NRPS/PKS hybrid interfaces of the
epothilone biosynthetic pathway.
(D) Acyl transfer assays for examining the ter-
minal effects of EpoB.
by the Ox domain with cofactor FMN to form methylthia- terminus of EpoB in constituting a functional EpoB/EpoC
interface. To this end we used noncognate PCPs from thezolyl-S-EpoB-PCP. EpoC, the downstream PKS partner,
then further elongates the final EpoB intermediate to coumermycin or yersiniabactin biosynthetic clusters as
the core domains on which the EpoB C-terminal resi-methylthiazolyl methacrylyl-S-EpoC (Figure 1C).
It has been proposed that the role of the terminal dues were grafted. The assay was acyl transfer from the
holo form of these constructs to methylmalonyl-S-EpoCsequences of EpoB may very well resemble functionally
the terminal linkers of PKS [28]. In this view, the pair- (Figure 1D).
wise interaction of the N- or C-terminal region of EpoB
with the corresponding terminal region of its up- or Results
downstream PKS partner would enable the productive
transfer of the acyl intermediate down the assembly line. Assay Design
To examine the EpoA/EpoB intersubunit communicationWe have previously reported that a C-terminal linker on
the PKS subunit EpoA in the form of the last 34 amino as reflected by productive acyl transfer, terminally trun-
cated forms of EpoA-ACP and EpoB were required. Foracid residues is portable, enabling noncognate ACP do-
mains to interface with EpoB [35]. Analogously, the 27 EpoA-ACP, the C-terminal truncation needed to be suit-
able for the stability of the protein and its ability to beC-terminal residues of EpoB were portable to enable
EpoC recognition [35]. acylated as acetyl-S-ACP. The N-terminal deletion of
EpoB, on the other hand, should not alter the loadingIn this work we have examined the existence of an
N-terminal linker in the NRPS subunit EpoB, analogous of cysteine onto EpoB-PCP (Table 1). The acyl transfer
reaction between a modified donor and acceptor pairto N-terminal PKS linkers, via deletions of 30 or 56 of the
N-terminal residues and assay of the consequences in was monitored by the formation of methylthiazolyl acid,
from hydrolyzed methylthiazolyl-S-EpoB, under single-acetyl transfer from the EpoA-ACP as donor. We have
also examined the role of six basic residues at the C turnover conditions (Figure 1D).
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Table 1. Terminal Sequences of the Mutant and Hybrid Proteins
EpoA-ACP (WT):
...SLMAVELRNRIEASLKLKLSTTFLSTSPNIALLTQNLLDA
LDALATALSLERVAAENLRAGVQSDFVSSGADQDWEIIAL
EpoB (WT):
TINQLLNELEHQGVKLAADGERLQIQAPKNALNPNLLARISEHKSTILTMLRQRLP
AESIVPAPAERHVPFPL
TDIQGS…(Cy-A-Ox-PCP)…
RRDSKDLEQRPNMQDRVEA RRKGRRRS
Constructs Sequence Modification from Wild-Type
EpoB(N-30) ALNPNLLARISEHKSTILTMLRQRLPAESIVPAPAERHVPFPLTDIQGS…
EpoB(N-56) AESIVPAPAERHVPFPLTDIQGS…
EpoA-ACP(C-10) …LDALATALSLERVAAENLRAGVQSDFVSSG
EpoA-ACP(C-20) …LDALATALSLERVAAENLRA
EpoA-ACP(C-34) …LDALAT
Ybt-PCP2(EpoB-8) …RRDSKDLEQRPNMQDRVEA
CouN5(EpoB) …RRDSKDLEQRPNMQDRVEARRKGRRRS
CouN5(EpoB-8) …RRDSKDLEQRPNMQDRVEA
CouN5(EpoB6G) …RRDSKDLEQRPNMQDRVEAGGGGGGGS
The phosphopantetheinylated serine residue is italicized. The proposed linker regions are bold. The regions found in this study to be essential
for elongation are italicized. Residues underlined indicate potential helical regions as predicted by online PSIPRED prediction programs
[46–47].
Comparably, to analyze recognition at the EpoB/EpoC and EpoA-ACP(C-20). The third break point was chosen
at the position after the 37th amino acid C-terminal tointerface by transfer of the acyl group on EpoB to meth-
the conserved phosphopantetheinylation serine site, fol-ylmalonyl-S-EpoC, it was necessary to generate those
lowing a known boundary definition for a minimal carrierrequisite acyl-S-proteins and to generate C-terminally
protein core to provide EpoA-ACP(C-34) [40]. All threemutated EpoB variants (Table 1). For these EpoB/EpoC
mutants again overexpressed successfully in BL21(DE3)acyl transfer assays, the C terminus of EpoB-PCP was
with yields in the range of 2–3 mg/l.grafted onto noncognate PCP core domains to minimize
Wild-type CouN5 was subcloned from a cosmid by PCRrecognition from elements that might be present at sites
techniques and overexpressed well in BL21(DE3) at 10within EpoB other than at the C terminus. One was the
mg/l. To generate a CouN5-EpoB C-terminal hybrid, a priorPCP2 domain from the HMWP2 protein of yersiniabactin
boundary definition [35] of a portable C-linker region ofsynthetase [37, 38], used by us previously [35] to study
EpoB, which includes the last 27 amino acids, was usedEpoB/EpoC communication, while the other was a free-
to construct the CouN5(EpoB) hybrid. CouN5, with itsstanding PCP subunit in the coumermycin biosynthetic
C terminus shorter than that of EpoB by 18 residues,pathway, CouN5 [36]. CouN5 is stable and soluble when
was treated as a naturally linkerless carrier protein. Theheterologously expressed in and purified from E. coli.
EpoB C-linker was appended to the last amino acid byIt has only 12% sequence similarity to EpoB-PCP and
splice overhang extension [39] to produce the CouN5lacks the stretch of basic residues seen at the C terminus
(EpoB) hybrid. This protein was overexpressed in BL21of EpoB.
(DE3) at 10 mg/l. The truncation mutants removing the
last eight residues, namely CouN5(EpoB-8) and YbtPC-Construction of the Mutant and Hybrid Proteins
P2(EpoB-8), were cloned using standard PCR tech-
Possible boundary definitions for the N linker of EpoB
niques and overexpressed under similar conditions, and
were determined as guided by secondary structural pre- the yields were comparable at 10 mg/l. The length-invari-
dictions. Two predicted helical regions, one from the ant but charge-removed mutant CouN5(EpoB6G) was
first residue to the 30th and the other from the 33rd to cloned in two sequential steps of mutating three
the 55th, were found. Break points, one after the 30th charged residues at a time to glycines. The loss of
amino acid from the N terminus and the other the 56th, charge again was not adverse to the overexpression
were therefore chosen to construct N-30 and N-56 mu- with the yield being 12 mg/l (Figure 2).
tant forms of EpoB. Both mutants were constructed All carrier proteins were constructed as N-terminally
using PCR techniques as N-terminally hexa-histidine His6-tagged proteins in pET-28 vectors and expressed
(His6)-tagged proteins in pET-28b vectors. The overex- in their apo-forms, since their heterologous overexpres-
pression conditions of both mutants in BL21(DE3) E. coli sion in E. coli did not result in significant modification
cells followed that of the EpoB wild-type [33] and re- by endogenous phosphopantetheinyl transferases
turned comparable yields at 2 mg/l for both. (PPTase) as determined by MALDI-TOF mass spectrom-
To examine the effect of C-terminal deletions in EpoA- etry (Table 2).
ACP, three C-terminally truncated mutants of EpoA-ACP
were also prepared analogously. Two break points were Sfp-Catalyzed Acylation of the Hybrid Apo-Carrier
chosen following the structural predictions that sug- Proteins with Acyl-CoAs
gested two helices formed by the last 20 amino acids For studying either the EpoA/EpoB or EpoB/EpoC linker
interface, the upstream acyl donor is consistently a car-at the C terminus, which gave rise to EpoA-ACP(C-10)
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B. subtillis, is a nonspecific PPTase found to have broad
substrate specificity for both carrier proteins and acyl-
CoAs and thus was used to directly modify the carrier
proteins from the apo-form to the acyl-form [41]. The
recognition of the carrier protein by Sfp has been shown
to depend on the second helix of the four-helix bundle
that typically defines the minimal core structure of a
carrier protein [42]. Although it is not known structurally
how the C terminus of a PCP from an NRPS would
interact with the four-helix bundle core, recent charac-
terizations of the C linker region of an ACP from the
DEBS PKS pathway [43] and PCP-Sfp [44] recognition
surface strongly suggest that the loading is unlikely to
be influenced by the C-terminal linker. Indeed, Sfp suc-
cessfully converted the apo-proteins to their acyl-forms,
regardless of the C-terminal variations, as shown by
MALDI-TOF mass spectrometry (Table 2). Specifically,
the PCPs were loaded with either the methylthiazolyl-
phosphopantetheinyl or picolinyl-phosphopantetheinyl
group, resulting in an increase in mass by 464 or 470
units, respectively. The ACPs, after being loaded with
the acetyl-phosphopantetheinyl group, provided an in-
crease of 382 units in mass.
A-Domain Activity AssessmentFigure 2. Purification of Carrier Proteins and EpoA and EpoB Mu-
tants of the EpoB Mutants
The first domain with recognized function from the N(A) SDS-PAGE gel of EpoA and EpoB deletion mutants. L  ladder;
1  EpoB WT; 2  EpoB(N-30); 3  EpoB(N-56); 4  EpoA-ACP; terminus of EpoB is the cyclization domain, followed by
5  EpoA-ACP(C-10); 6  EpoA-ACP(C-20); 7  EpoA-ACP(C-34). the A domain that activates L-Cys to L-Cys-AMP to form
(B) SDS-PAGE gel of the carrier proteins with various C-terminal cysteinyl-S-EpoB-PCP. This domain activity is typically
regions imported from EpoB. L  ladder; 1  CouN5 WT; 2 
assessed by the ATP-32PPi exchange assay [45], whichCouN5(EpoB); 3  CouN5(EpoB-8); 4  CouN5(EpoB6G); 5  Ybt-
measures the formation of 32P-ATP from aminoacyl-AMPPCP2(EpoB-8).
with 32PPi. It was necessary to examine if the removal
of part of the N terminus of EpoB would change the
activity of the A domain that is in proximity. A compro-rier protein with an acyl group covalently attached
through the phosphopantetheinyl prosthetic group. Nor- mised A-domain activity would obscure the interpreta-
tions of the elongation efficiency at the EpoA/EpoB in-mally, a carrier protein domain needs to be first primed
into its holo-form by a PPTase that catalyzes covalent terface.
To compare the A-domain activity of EpoB-WT withattachment of the prosthetic group through a phospho-
diester linkage to the conserved serine site on the carrier the two N-terminal mutants, all three proteins were first
modified with Sfp to convert from the apo-form to theprotein. An additional catalytic domain then further con-
verts the holo-form into the acyl-form. Sfp, isolated from holo-form using coenzyme A. The holo-EpoBs were then
Table 2. MALDI-TOF Mass Analysis of Carrier Proteins Loaded with Acyl Groups
Calculated [MH] Observed [MH]
Carrier Proteins (Acyl Group) Apo- Acyl- Apo- Acyl-
EpoA-ACP(-10)(acetyl) 15,370 15,752 15,395 15,790
EpoA-ACP(-20) (acetyl) 14,406 14,788 14,434 14,822
EpoA-ACP(-34) (acetyl) 12,917 13,299 13,299 13,311
Ybt-PCP2(EpoB-8) (methylthiazolyl) 14,088 14,552 14,124 14,585
CouN5 (methylthiazolyl) 11,755 12,219 11,744 12,203
CouN5(EpoB) (methylthiazolyl) 15,576 16,040 15,556 16,034
CouN5(EpoB-8) (methylthiazolyl) 14,522 14,986 14,515 14,982
CouN5(EpoB6G) (methylthiazolyl) 15,007 15,471 15,031 15,504
CouN5 (picolinyl) 11,755 12,225 11,755 12,213
CouN5(EpoB) (picolinyl) 15,576 16,046 15,556 16,044
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incubated with L-Cys in the presence of ATP and 32PPi
for five minutes. The 32P-ATP formed was isolated and
subjected to radioactivity counting. The measured kcat
for the A domain activity of wild-type EpoB was 20/min.
The two mutants, one at 157 kDa (N-30) and the other at
154 kDa (N-56), both displayed robust A-domain activity
comparable to that of EpoB wild-type with kcat values of
33/min and 45/min, respectively.
The First 56 Amino Acids at the N Terminus
of EpoB
To test if there is a sequence requirement at the N termi-
nus of EpoB for the functional constitution of the EpoA/
EpoB interface, the elongation efficiencies of EpoB
(N-56) were examined in the presence of either EpoA-
ACP WT or EpoA-ACP(C-34). It has previously been
shown that the last thirty-eight amino acid residues of
EpoA-ACP is a portable recognition sequence that en-
ables productive elongation between a noncognate ACP
and EpoB to form methylthiazolyl-S-EpoB [35]. Elonga-
tion efficiencies of three interfaces, acetyl-S-EpoA-ACP
WT/cysteinyl-S-EpoB WT, acetyl-S-EpoA-ACP WT/cys-
teinyl-S-EpoB(N-56), and acetyl-S-EpoA-ACP(C-34)/
cysteinyl-S-EpoB(N-56), were assessed by measuring
the formation of 35S-labeled methylthiazole carboxylic
acid hydrolyzed from [35S]-methylthiazolyl-S-EpoB after
three time points of 30, 90, and 250 min. Reactions were
also repeated at two concentrations of acetyl-CoA of
50 M and 200 M in the absence of the carrier protein
as the background for carrier protein independent prod-
uct formation. The wild-type interface provided the an-
ticipated elongation product over the time course (Fig-
ure 3A). Truncating the first fifty-six amino acids of EpoB
resulted in only background product formation. The
same effect was confirmed by the result from the inter-
face formed by acetyl-S-EpoA-ACP(C-34) and cysteinyl-
S-EpoB(N-56).
Partial terminal truncation mutants of the EpoA/EpoB
interface, EpoA-ACP(C-10) and EpoA-ACP(C-20), and
EpoB(N-30), were also constructed. The elongation as-
sessment was repeated under identical conditions for
these mutants for 120 min. In the case with EpoB WT,
deleting the first 10 or 20 amino acids from the C termi-
nus of EpoA-ACP provided nearly identical transfer effi-
ciencies to that with wild-type EpoA-ACP. Removing
the N-terminal 30 amino acids of EpoB, on the other
hand, resulted in substantial loss of elongation but not
yet reduced to the background level (Figure 3B).
To confirm that the N terminus EpoB is not the only
Figure 3. The N-Terminal Region of EpoB
(A) Time courses (three time points of 30, 90, and 250 time points) of (C) Time courses (3 time points of 30, 90, and 250 time points)
acetyl transfer reactions between EpoA-ACP(C-34) and EpoB(N-56). of acetyl transfer reactions between EpoA-ACP(C-34) and EpoB,
S  methylthiazole acid standard; C  Cospotting of standard and compared to that between RapC-ACP and EpoB (N-56). Smethyl-
EpoA-ACP WT and EpoB WT transfer reaction after 250 min. Lanes thiazole acid standard. The positive control is the acetyl transfer
1–3 are transfer reactions between EpoA-ACP WT and EpoB WT. reaction between EpoA-ACP WT and EpoB WT after 250 min. Lanes
Lanes 4–6 are transfer reactions between EpoA-ACP WT and 1–3 are transfer reactions between EpoA-ACP(C-34) and EpoB-WT.
EpoB(N-56). Lanes 9–11 are transfer reactions between EpoA-ACP Lanes 4–6 are acetyl transfer reactions between RapC-ACP WT and
(C-34) and EpoB(N-56). Lanes 7 and 8 are negative control reactions EpoB(N-56). Lane 7 is the negative control reaction where the carrier
where the carrier protein was absent in the transfer reaction in two protein was absent in the transfer reaction with 50 M of acetyl-
different acetyl-CoA concentrations of 50 and 200 M, respectively. CoA.
(B) One time point assessment (120 min) of acetyl transfer reaction (D) One time point assessment (120 min) of acetyl transfer reaction
using EpoA-ACP(C-10), EpoA-ACP(C-20), and EpoB (N-30). The using RapC-ACP(EpoA), EpoB(N-30) and EpoB(N-56). The standard
standard is methylthiazole acid. is methylthiazole acid.
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factor involved in productive elongation at the EpoA/
EpoB interface, a C-linker removed truncation of EpoA-
ACP, EpoA-ACP(C-34), was examined in the presence
of the EpoB wild-type. The elongation efficiency of this
interface was reduced to the background level again.
This is consistent with the previous report showing that
a noncognate interface formed between RapC-ACP, an
ACP from the rapamycin pathway, with EpoB requires
the presence of the EpoA-ACP C-linker [35]. To further
examine if the N terminus of EpoB is merely a steric-
gating element, acetyl-S-RapC-ACP was incubated with
cysteinyl-S-EpoB(N-56) to test if the lack of the N termi-
nus would permit an otherwise rejected upstream donor
to regain recognition. This noncognate interface again
did not provide protein-dependent methylthiazole car-
boxylic acid formed as indicated by 35S radio-HPLC (Fig-
ure 3C).
The studies with N-truncated EpoB were conducted
with another form of ACP acyl donor: a hybrid between
the RapC ACP domain and the last 38 residues of EpoA
[35]. In this case, RapC can only interface with EpoB
when it has the EpoA C-terminal linker attached. Incuba-
tions were repeated with this potential acetyl donor to
Cys-S-EpoB. Cysteinyl-S-EpoB(N-30), while able to pro-
ductively interface with acetyl-S-EpoA-ACP, showed
severe reduction in elongation efficiency when reacted
with acetyl-S-RapC-ACP(EpoA). In the case of Cystei-
nyl-S-EpoB(N-56), elongation was entirely lost with ace-
tyl-S-RapC-ACP(EpoA) (Figure 3D), indicating the elon-
gation effect by importing the C-linker of EpoA requires
the presence of the N terminus of EpoB.
The Basic Charge Cluster at the C Terminus
of EpoB
To test if the basic residues at the C terminus of EpoB
are sufficient and necessary to interface with EpoB’s
downstream acceptor EpoC, CouN5, a noncognate carrier
Figure 4. The Charge Cluster of the C-Terminal Linker of EpoBprotein, was chosen to minimize contributions from non-
(A) Time courses of CouN5 and CouN5(EpoB) transferring methylthi-linker regions. CouN5 was loaded with the methylthiazo-
azolyl and picolinyl acyl groups to EpoC over three time points (20,lyl group in the presence of Sfp and methylthiazolyl-CoA
60, and 180 min). Lanes 1–3, methylthiazolyl-S-CouN5(EpoB) and[35], yielding methylthiazolyl-S-CouN5 as the upstream
methylmalonyl-S-EpoC; lanes 4–6, methylthiazolyl-S-CouN5 and meth-
acyl donors for EpoC. The formation of the elongated ylmalonyl-S-EpoC; lanes 7–9, picolinyl-S-CouN5(EpoB) and methylmal-
product methylthiazolyl methacrylyl-S-EpoC, as de- onyl-S-EpoC; lanes 10–12, picoliny-S-CouN5 and methylmalonyl-S-
tected by the formation of 14C-labeled methylthiazolyl EpoC. SA  methylthiazolyl methyl acrylic acid standard; SB 
picolinyl methyl acrylic acid standard.methyl acrylic acid after hydrolyzing the small molecule
(B) Time courses of CouN5, CouN5(EpoB), and CouN5(EpoB-8)off EpoC, was monitored for several hours. Product for-
transferring methylthiazolyl group to EpoC (five time points of 30,mation was not observed over the time course, indicat-
90, 150, 300, and 480 min). The positive control was the transfer
ing that CouN5 by itself is not capable of interacting reaction between CouN5(EpoB) and EpoC for 480 min. The negative
with EpoC productively. control was the transfer reaction in the absence of the carrier protein.
The twenty-seven amino acid EpoB C-linker was then Lanes 1–5: methylthiazolyl-S-CouN5(EpoB-8) and methylmalonyl-
S-EpoC; lanes 6–10: methylthiazolyl-S-CouN5 and methylmalonyl-appended to the C terminus of CouN5, providing a non-
S-EpoC.cognate hybrid carrier protein CouN5(EpoB). This hybrid
(C) The charge-cluster truncated mutant, Ybt-PCP2(EpoB-8), of pre-protein was again successfully loaded with the methyl-
viously reported Ybt-PCP2(EpoB) hybrid carrier protein reduced the
thiazolyl group and combined with methylmalonyl-S- pseudo-first order rate of product formation by 2-fold. Carrier pro-
EpoC. The formation of methylthiazolyl methacrylyl-S- teins were at 3 M and EpoC 15 M.
EpoC was observed shortly after initiation of the transfer (D) Comparison of elongation efficiencies after 60 min of three con-
structs: CouN5(EpoB), CouN5(EpoB6G), and CouN5.reaction. To show that the acyl group being transferred
does not influence the linker-dependent elongation, an-
other heterocyclic acyl group was examined as well.
The C-terminally modified picolinyl-S-CouN5 acyl do- with transferring the methylthiazolyl group, the forma-
tion of picolinyl methacrylyl-S-EpoC required the C-ter-nors were prepared by using Sfp and picolinyl-CoA and
subjected to identical transfer reactions. In agreement minal linker of EpoB (Figure 4A).
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Truncation mutagenesis was applied to CouN5(EpoB) CouN5, a PCP that required this C-linker of EpoB to
elongate either methylthiazolyl or picolinyl acyl groupsto give CouN5(EpoB-8), removing the last eight amino
acids. The new construct was loaded with methylthiazo- to EpoC. This noncognate hybrid interface also allowed
for identification of the basic residues clustered in thelyl group and subjected to the transfer reaction to EpoC.
In the absence of the charge cluster in those last eight last 8 amino acids as a key factor for enabling the non-
cognate elongation. Truncation or removal of the chargeresidues, the methylthiazolyl methacrylyl-S-EpoC for-
mation was abolished (Figure 4B). To confirm the effect residues negates the positive effect of the imported
C-linker. Since an excised EpoB-PCP itself could notof the charge truncation without the possibility of false
negative outcome, Ybt-PCP2(EpoB-8), which is a charge- be accessed as a stable domain, Ybt-PCP2(EpoB) has
been used and reported as a homologous surrogate. Thetruncation mutant using the Ybt-PCP2 core domain, was
also examined. It has been shown that Ybt-PCP2(NL), C-linker of EpoB, while sufficient in enabling noncognate
hybrid interfaces for PCPs nonhomologous to EpoB-a C-linker truncated version of the native PCP2, can still
interface productively with EpoC for elongation, al- PCP, is not the sole factor in constituting the native
EpoB/EpoC interface, as the linkerless Ybt-PCP2(NL)though at half of the efficiency of PCP2(EpoB), a con-
struct of PCP2 that contains the EpoB C-linker [35]. could still enable acyl transfer and chain elongation to
EpoC [35], albeit less efficiently. However, the findingsYbt-PCP2(EpoB-8) exhibited a pseudo-first order rate
of 0.03/min in forming methylthiazolyl methacrylyl-S- from the Ybt-PCP2(EpoB-8) indicated that the enhanc-
ing effect of the linker requires the charges, confirmingEpoC, which is half of that observed for PCP2(EpoB) at
0.06/min, indicating that the effect of charge truncation again the observation made from the case of CouN5.
This charge cluster-controlled linker effect is differenton elongation is equivalent to that of linker removal.
Although only 20% of all loaded methylmalonyl-EpoC from that reported for the PKS linkers where interactions
of both hydrophilic and hydrophobic nature are spreadwas converted to methylthiazolyl methacrylyl-S-EpoC
due to competing hydrolysis of methylmalonyl- through extended coiled-coiled surfaces formed by the
linkers [27]. Potential C-linkers at other S/PKS inter-EpoC during the acyl transfer reaction, the captured
methylmalonyl-EpoC was nearly all converted to the sta- faces, as seen in the bleomycin and yersiniabactin path-
ways, also contain basic charge clusters [28]. The gener-ble methylthiazolyl methacrylyl-S-EpoC product (Fig-
ure 4C). ality of this type of charge-cluster effect, if established,
will help formulating future linker engineering or evolu-To ensure that the effect of charges is not due to
the shortening of the linker length, a length-invariant tion strategies for hybrid NRPS/PKS systems.
For the EpoA/EpoB (PKS/NRPS) interface, the N-ter-construct CouN5(EpoB6G), in which the six basic resi-
dues were uniformly mutated to glycine, was subjected minal 56 amino acids were found to be required for
elongating the natural acetyl group from EpoA-ACP toto the acyl transfer and elongation reaction to EpoC.
The removal of the charges rendered CouN5(EpoB6G) EpoB. This part of the N terminus seems modular, since
the removal of this region did not alter the A-domaina poor acyl donor to EpoC (Figure 4D).
activity as judged by the ATP-PPi exchange assay. Given
a previously reported portable C-linker of EpoA-ACP
Discussion containing 34 amino acids, it is now evident that, at the
EpoA/EpoB interface, the intersubunit terminal regions
The findings in this report establish the crucial role and show comparability in length and modularity to the link-
minimal sequence definition of the terminal regions of ers from the PKS systems. Truncations less complete,
EpoB at the PKS/NRPS/PKS hybrid interfaces formed as shown by EpoA-ACP(C-10), EpoA-ACP(C-20), and
by EpoA, EpoB, and EpoC, the initial three subunits of EpoB(N-30), could measurably reduce the elongation
the epothilone pathway. As an initial investigation on efficiency but not prevent it entirely. A complete C-linker
the intersubunit linkers of an NRPS module in a hybrid truncation on EpoA-ACP duplicated the detrimental ef-
environment, it begins to address the important ques- fect on elongation seen for EpoB(N-56), suggesting the
tion of how protein-protein interactions must occur to equally important role of the C terminus of EpoA.
ensure elongation as the assembly line switches first The definition at the primary sequence level for the
from a PKS logic to an NRPS one, and then back again functional role of the N terminus of EpoB for elongation
to the PKS logic. PKS subunits are dimeric while NRPS sets the stage for investigating the secondary, tertiary,
ones are generally monomeric, a discrepancy that and quaternary characteristics of the EpoA/EpoB termi-
makes hybrid NRPS and PKS interfaces more difficult nal interface. The question remains if EpoB needs to be
to decipher. The previously defined linker effect of purely a dimer or monomer, under the constraint of differing
PKS systems [24] served as an initial guide to the exis- quaternary models previously described for the PKS and
tence of intersubunit linkers in hybrid NRPS subunits. NRPS proteins [16–22]. Similar investigation is needed
The experimental evidence presented here for the cru- for the EpoB/EpoC interface, although the scenario is
cial roles of the N-terminal 56 amino acids and C-ter- different from that of EpoA/EpoB and other typical PKS
minal 8 amino acids of EpoB in enabling a functional interfaces, in that the EpoB C-linker effect appears to
PKS/NRPS/PKS hybrid line corroborates this idea at the be concentrated on one basic charge cluster. The strat-
primary sequence level. egy of covalently joining linker pairs for direct structural
For the EpoB/EpoC (S/PKS) interface, we have estab- characterization as reported for the DEBS PKS system
lished previously that the C-terminal 27 amino acids can [43] will likely be applicable for EpoB with the availability
serve as a portable C-linker [35]. The generality of this of some information at the quaternary level to help de-
sign the construct. As the first NRPS from a hybrideffect was supported in this report by the example of
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and then 5-GGA ATT AGC GGC CGC TTA GCT GCC GCC GCCNRPS-PKS pathway to show defined modular terminal
GCC GCC GCC GCC AGC-3. The insert generated from the secondregions essential for elongation, EpoB serves as a proto-
round PCR was digested and ligated into a pET-28a vector.type to test if these characteristics may be extendable
All EpoA-ACP mutants were cloned in pET-28b using NdeI and
to other proteins from hybrid S-PKS systems. From the BamHI restriction sites, sharing the same forward primer 5-G GAA
combinatorial biosynthesis point of view, modification TTC CAT ATG GCA GGC GCC GGC CCG TCC ACC. The reverse
primers for EpoA-ACP(C-10), (C-20), and (C-24) were 3-CGC GGAor optimization in these crucial regions will be a key
TCC TTA GCC CGA TGA GAC GAA GTC GCT, 3-CGC GGA TCCvariable leading to additional noncognate hybrid path-
TTA TGC CCG TAG GTT CTC CGC CGC, and 3-CGC GGA TCCways for producing epothilone variants.
TTA TGT GGC GAG AGC ATC CAA CAG, respectively.
A full-length EpoB gene in pET-28b was used as the template for
Significance cloning the EpoB mutants and amplified using primers containing
NdeI and AvrII restriction sites. Both EpoB mutants shared the same
reverse primer 3-C AGG CTG CCT AGG TCA ACG TTA ATG AGANRPS and PKS biosynthetic pathways have been
TCG. The forward primers were 5-G GAA TTC CAT ATG GCC CTGfound to converge and form mixed assembly lines to
AAC CCG AAC CTG CTC for EpoB(N-30) and 5-G GAA TTC CAT
produce hybrid natural products comprised of NRP ATG GCA GAG TCC ATC GTG CCC GCC for EpoB(N-56). The PCR
and PK features. Many of these hybrid natural prod- products were then digested and ligated with the full-length EpoB
ucts, for example the epothilones, are medicinally im- vector double-digested using NdeI and AvrII restriction enzymes.
portant. Although the pure NRP or PK biosynthetic
Overexpression and Purificationpathways have received much attention, the hybrid/PK
BL21(DE3) cells (Invitrogen) were used in all overexpressions. Theassembly lines have just begun to emerge as complex
procedure for the carrier proteins is in general as follows: cells weresystems to be examined. Given the divergent quater-
grown in LB medium in the presence of 50 g/ml of kanamycin at
nary characteristics of NRPS and PKS, it is essential 37C to an OD600 of 0.5–0.6, cooled to 22C, induced with 1 mM IPTG
to understand how the hybrid systems operate at the for 3.5–12 hr, and centrifuged. The harvested cells were resus-
molecular level, a prerequisite to optimizing future pended in a lysis buffer (20 mM Tris [pH  7.6], 500 mM NaCl, 5%
glycerol, and 5 mM imidazole) and lysed by passing twice throughprotein engineering or evolution effort for combinato-
French Press. The lysates were centrifuged at 4C (30 min atrially synthesizing “unnatural” variants of natural prod-
35,000  g), and to the supernatant was added immediately 1 mlucts. This study defines minimal terminal regions of
of Ni-NTA resin (Qiagen). Binding was allowed for 4 hr at 4C, after
EpoB required for constituting the functional hybrid which the resin was washed with 20 ml of the lysis buffer and eluted
PKS/NRPS/PKS interface formed by EpoA, EpoB, and with increasing concentrations of imidazole (Sigma, 20 mM, 30 mM,
EpoC, the initial three protein subunits of the epothi- 100 mM, and 500 mM) in the lysis buffer. The proteins were dialyzed
(3  1 liter of 20 mM Tris [pH  7.6], and 5% glycerol) and storedlone biosynthetic pathway. Although modular like the
at 80C. The protein concentrations were determined using thePKS linkers, these regions were found to have different
Bradford assay (Bio-rad). MALDI-TOF mass spectroscopy (Danathemes for recognition, in that the C-terminal linker
Faber Cancer Institute) was performed for all carrier proteins, which
effect of EpoB concentrates on one basic charge clus- were found to be in the demethioninated apo-form.
ter while the elongation effect of the N terminus of For the EpoB mutants, growth was maintained at 15C for 72 hr
EpoB is spread over 56 amino acids. without induction, and the purification procedure was followed as
described previously [33]. Anion-exchange (MonoQ, Pharmacia)
was used to further purify the 157 kDa and 154 kDa mutants afterExperimental Procedures
the Ni-column. The eluent system was 25 mM Tris buffer at pH 8.0
(A) in 50 mM NaCl and 25 mM Tris buffer at pH 8.0 in 500 mM NaClCloning of the Carrier Proteins and EpoB Mutants
(B). The gradient was from 0%–100% B in 90 min at 4 ml/min flowThe pET-28 vectors (Novagen) were used for subcloning all proteins.
rate. The fractions containing pure proteins were pooled, concen-Restriction enzymes and T4 DNA ligase were purchased (New En-
trated, dialyzed against 20mM Tris (pH 7.5), 50 mM NaCl, 1 mMgland Biolabs). A vector containing Ybt-PCP2(EpoB) [35] was used
TCEP, and 10% glycerol, and stored at 80C. Protein concentra-for as a template for subcloning Ybt-PCP2(EpoB-8). PCR amplified
tions were determined using the Bradford assay.genes were digested with NdeI and NotI restriction enzymes and
ligated into pET-28b. Clones were characterized by DNA sequencing
Enzymic Synthesis of Acyl-S-Carrier Proteins(Dana Farber Cancer Institute) and confirmed. For Ybt-PCP2(EpoB-
A typical reaction (20 l) contained 10 M PCP or ACP, 100 M8), the primers were 5-GAA TTC CAT ATG GCA GAG CGC TCC
acyl-CoA, 50 mM Tris (pH 7), 5 mM MgCl2, and 0.5 M Sfp. After anCCG CGC GTA TGC-3 (forward) and 5-G GGA ATT AGC GGC CGC
hour at 37C, the proteins were purified using ZipTip (C4, Millipore).TTA AGC CTC CAC TCG GTC-3 (reverse).
MALDI-TOF mass spectrometry was performed using -sinapinicCouN5 was subcloned using NdeI and EcoRI with primers 5-GTC
acid (10 mg/ml in 60% acetonitrile/water) as the matrix.ATA CAT ATG GCA ACC CAG ACC CGA GAA GAC-3 and 5-CAG
TGC GAA TTC TTA CTT CCG CGA CAG GCT CTC ATG C-3.
CouN5(EpoB) was cloned using splicing by overlap extension. The ATP-PPi Exchange Essay for A Domain Activity of EpoB
As described before [33, 45], reactions (100 l) were initiated bytwo templates used for the first round of PCR were plasmids con-
taining CouN5 and EpoB. For CouN5, the primers were 5-GTC ATA adding the EpoB protein in a final solution containing 100 nM EpoB
protein, 75 mM Tris (pH 7.5), 10 mM MgCl2, 5 mM TCEP, 3 mMCAT ATG GCA ACC CAG ACC CGA GAA GAC-3 (N) and 5-CAA
ACC GGA CGC CAG CTT CCG CGA CAG GCT-3(N’). For EpoB, the ATP, 1.5 mM L-cysteine, and 1 mM [32P]pyrophosphate with specific
activity at 302 Ci/mmol made from a mixture of pyrophosphateprimers were 5-AGC CTG TCG CGG AAG CTG GCG TCC GGT TTG-
3 (C) and 5-CAG TGC GAA TTC TTA GCT ACG TCT CCT GCC-3 and [32P]pyrophosphate from Perkin Elmer (55 Ci/mmol). After five
minutes at room temperature, reactions were quenched with 500 l(C’). For the second round of PCR, the primers were N and C with
the two PCR products from the first round of PCR combined as the of charcoal suspensions (1.6% [w/v] activated charcoal, 4.5% [w/v]
tetrasodium pyrophosphate, and 3.5% perchloric acid in water).template. CouN5(EpoB-8) was subcloned analogously as described
for Ybt-PCP2(EpoB-8), using primers N and 5-CAG TGC GAA TTC Centrifugation was applied to provide the charcoal pellet. The pellet
was then washed with the wash solution (4.5% [w/v] tetrasodiumTTA AGC CTC CAC TCG GTC CTG-3. CouN5(EpoB6G) was con-
structed by two sequential PCR steps, using the same forward pyrophosphate and 3.5% perchloric acid in water) twice, resus-
pended in water and counted in a scintillation counter (Beckmanprimer N and two reverse primers in tandem: first 5-G GGA ATT
AGC GGC CGC TTA GCC GCC GCC AGC CTC CAC TCG GTC-3 LS6500.)
Minimal Terminal Sequences of Hybrid NRPS EpoB
1541
Single-Turnover Elongation Reactions from Carrier Proteins 2. Staunton, J., and Weissman, K.J. (2001). Polyketide biosynthe-
sis: a millennium review. Nat. Prod. Rep. 18, 380–416.to EpoC
In a typical reaction, the carrier protein was first subjected to the 3. Cane, D.E., and Walsh, C.T. (1999). The parallel and convergent
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